Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
18%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
PBE
28
HOLDINGS
21%
ALSO IN IBRN
IBRN
60
HOLDINGS
15%
ALSO IN PBE
SECTOR DRIFT (PBE minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PBE |
Weight in IBRN |
Overlap | |
---|---|---|---|---|
BIOGEN IDEC INC | 5.0% | 3.9% | 3.9% | |
PTC THERAPEUTICS INC | 3.2% | 4.1% | 3.2% | |
NEUROCRINE BIOSCIENCES INC | 2.8% | 3.9% | 2.8% | |
SAREPTA THERAPEUTICS INC | 2.7% | 2.9% | 2.7% | |
CATALYST PHARMACEUTICAL PART | 2.7% | 3.7% | 2.7% |
PBE Overweight Relative to IBRN
VERTEX PHARMACEUTICALS INC | 4.9% | |
INCYTE CORP | 4.9% | |
GILEAD SCIENCES INC | 4.9% | |
ROYALTY PHARMA PLC CLASS A | 4.8% | |
REGENERON PHARMACEUTICALS | 4.8% | |
AMGEN INC | 4.7% | |
ILLUMINA INC | 4.6% | |
IONIS PHARMACEUTICALS, INC. | 4.1% | |
UNITED THERAPEUTICS CORP | 3.8% | |
EXACT SCIENCES CORP | 3.1% |
PBE Underweight Relative to IBRN
SCHOLAR ROCK HOLDING CORP. | -4.9% | |
SUPERNUS PHARMACEUTICALS INC | -4.1% | |
ARGENX SE ADR | -3.8% | |
AXSOME THERAPEUTICS, INC. | -3.7% | |
ALKERMES PLC | -3.7% | |
SK BIOPHARMACEUTICALS CO., LTD. | -3.5% | |
DENALI THERAPEUTICS INC. | -3.0% | |
DYNE THERAPEUTICS INC | -2.5% | |
EDGEWISE THERAPEUTICS, INC. | -2.1% | |
SANBIO CO., LTD. | -1.5% |